The site in Hopewell will now incorporate an additional 26,000 square feet of drug substance manufacturing suites, laboratories, storage, dispensing and warehousing.
The CDMO is entering the advanced therapy manufacturing space with the installation of its third FlexFactory platform from Cytiva to meet demand for genomic medicines.